Back to top

Image: Bigstock

Community Health Systems (CYH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Read MoreHide Full Article

For the quarter ended June 2026, Community Health Systems (CYH - Free Report) reported revenue of $2.83 billion, down 9.8% over the same period last year. EPS came in at -$0.19, compared to -$0.05 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $2.9 billion, representing a surprise of -2.54%. The company delivered an EPS surprise of -5.56%, with the consensus EPS estimate being -$0.18.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Community Health Systems performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Adjusted admissions: 196,917 compared to the 199,173 average estimate based on two analysts.
  • Patient days: 365,978.00 Days versus the two-analyst average estimate of 416,294.50 Days.
  • Beds in Service: 7,665 versus 7,067 estimated by two analysts on average.
  • Same-store occupancy rate (average beds in service): 50.8% compared to the 64.7% average estimate based on two analysts.
  • Number of Hospitals: 60 compared to the 59 average estimate based on two analysts.
  • Admissions: 86,715 compared to the 92,707 average estimate based on two analysts.
  • Licensed Beds: 8,863 compared to the 8,879 average estimate based on two analysts.

View all Key Company Metrics for Community Health Systems here>>>

Shares of Community Health Systems have returned +4.2% over the past month versus the Zacks S&P 500 composite's +0.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Published in